Universiteit Gent — Clinical Trial Site

26 Registered trials

9 Currently recruiting

Organisation

Universiteit Gent

Location

Gent, Belgium

Identifier

ORG-100022735

Address

Ottergemsesteenweg 460, Verdieping 2de, 9000, Belgium

Departments

Department of Ophthalmology
Drug Research Unit Ghent
Haematology
Hematologie
Hematology
Hospital - Universitair Gent __Neurology Department
Intensive Care Medicine
Medical Oncology
NA
Nefrologie kinderen
Nephrology
Neurology
Neuromusculair referentiecentrum
Oncologisch centrum
Oncology
Pediatric Hemato-Oncologogy & Stem Cell Transplant
Pediatrische hemato-oncologie
Urology
Vakgroep Diagnostische Wetenschappen

Clinical trials at this site (26)

Search interface

A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a single dose of REGN22044 in Healthy Adults Pending

2025-523562-24-00 Heathy volunteer trial 1
A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat… Pending

2025-523735-19-00 Metastatic Microsatellite Stable Colorectal Cancer 5
A Ph2 Superiority Study with InO Monotherapy vs ALLR3 for Induction Treatment of Childhood HR ALL Recruiting

2023-509810-13-00 Acute Lymphoblastic Leukemia (ALL) 4 2023-05-13
A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zos… Recruiting

2022-502784-37-00 Prevention of Herpes Zoster in immunocompromised subjec 4 2019-09-03
Pasritamig vs Placebo in late line Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-520927-26-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-11-24
A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK4771261 in healthy participants and participants w… Recruiting

2024-516095-15-00 Kidney Disease 1 2025-08-05
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Recruiting

2024-520154-38-00 Acute Myeloid Luekemia 5 2025-07-29
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 … Recruiting

2022-500747-21-00 Geographic Atrophy 4 2025-02-27
An investigator-initiated, single-center academic study in healthy transgender and cisgender persons aged between 18 and 50 years to investi… Recruiting

2024-515599-11-00 Healthy volunteers 6 2025-01-30
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
Allogeneic hematopoietic cell transplantation from HLA-matched donor after Flu-Mel-PTCy versus Flu-Mel-ATG reduced-intensity conditioning: a… Recruiting

2024-518568-11-00 Hematological malignancies confirmed histologically: - 4 2019-02-04
An open-label study to collect safety and effectiveness information on long-term treatment with vamorolone in boys with Duchenne Muscular Dy… Ended

2024-512828-12-00 Duchenne Muscular Dystrophy 6 2024-12-05
A study to test Taldefgropeb Alfa in patients with Spinal Muscular Atrophy. Ended

2024-511852-42-00 Spinal Muscular Atrophy 5 2023-01-19
A Phase 3 Study of Rusfertide (PTG-300) in Patients with Polycythemia Vera Ended

2023-509750-58-00 Polycythemia Vera 5 2022-09-21
A phase 1/1b/2 study of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors. Ended

2023-504363-17-00 Advanced MTAP-null solid tumors 7 2022-05-13
A Phase 3 Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant Ended

2023-508897-27-00 Multiple Myeloma 5 2022-04-28
An open-label phase 1b/2 study assessing the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic… Ended

2024-514905-79-00 Metastatic pancreatic ductal adenocarcinoma 9 2021-09-17
CREST - Phase 3 Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) or as a Single Agent in Participants Wi… Ended

2023-509089-39-00 Non-Muscle Invasive Bladder Cancer 5 2020-07-01
A Randomized Study Comparing JNJ-68284528 versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexametha… Ended

2023-506588-32-00 Relapsed and Lenalidomide-Refractory Multiple Myeloma 5 2020-06-12
A study to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease Ended

2024-513884-20-00 Fabry disease 5 2019-03-13
The effect of strict blood glucose control within normal fasting ranges, with insulin adjusted according to the Leuven algorithm, in adult c… Ended

2023-510358-17-00 Hyperglycemia in critically ill patients (stress hyperg 5 2018-09-01
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP. Ended

2024-512646-42-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2023-06-27
EvAluation of the efficacy of MaaT013 as salvage theRapy in acute GVHD patiEntS with gastrointestinal involvement, refractory to ruxolitinib… Ended

2024-513023-17-00 Treatment of acute graft-versus host disease (aGvHD) to 5 2022-01-12
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study with a Long-Term Extension Treatment Period to Assess the … Ended

2022-501188-42-00 Early Alzheimer's Disease 4 2021-04-15